In this inaugural episode of ATTD Diabetes Talks: The Power of Weekly Insulin, we delve into the evolution and future of basal insulin therapy. Host Diana Isaacs sits down with Dr. Rodolfo Galindo to explore the pharmacological innovations behind weekly insulin formulations and discuss how this breakthrough is reshaping modern diabetes management.
Guest: Dr. Rodolfo Galindo (Associate Professor of Medicine and Director of the Comprehensive Diabetes Center at the University of Miami Health System)
Key Topics Covered:
The Evolution of Basal Insulin: A look back at the progression from early long-acting formulations to current weekly treatment options.
Pharmacological Innovation: Understanding the science that makes weekly insulin formulations possible.
Clinical Advantages: Exploring the theoretical benefits of weekly versus daily basal insulin.
Patient Impact: Examining how shifting to a weekly regimen affects treatment burden and overall patient experience.
Future Outlook: How weekly insulin is poised to fit into the broader landscape of diabetes care.
Podden och tillhörande omslagsbild på den här sidan tillhör
ATTD on Unlok. Innehållet i podden är skapat av ATTD on Unlok och inte av,
eller tillsammans med, Poddtoppen.